CliffBio
small molecule

AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER

MOXIFLOXACIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameAVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
Active ingredientMOXIFLOXACIN HYDROCHLORIDE
Strength400MG/250ML (1.6MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalNovember 2001
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.